Robert L Findling Selected Research

Molindone (Molindone Hydrochloride)

1/2021	A Double-Blind, Randomized Study of Extended-Release Molindone for Impulsive Aggression in ADHD.
3/2019	A proposed anti-maladaptive aggression agent classification: improving our approach to treating impulsive aggression.
5/2012	Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study.
4/2012	A phase 2a randomized, parallel group, dose-ranging study of molindone in children with attention-deficit/hyperactivity disorder and persistent, serious conduct problems.
6/2010	Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study.
11/2008	Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study.
8/2007	Treatment of early-onset schizophrenia spectrum disorders (TEOSS): rationale, design, and methods.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert L Findling Research Topics

Disease

79	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2022 - 03/2002
46	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 08/2003
26	Mania (Manias) 01/2022 - 06/2005
24	Schizophrenia (Dementia Praecox) 01/2022 - 02/2003
17	Weight Gain 09/2019 - 08/2007
15	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 06/2004
14	Sleepiness 01/2022 - 08/2002
13	Headache (Headaches) 01/2022 - 08/2002
11	Body Weight (Weight, Body) 01/2022 - 08/2006
10	Mental Disorders (Mental Disorder) 01/2020 - 01/2002
9	Nausea 01/2022 - 06/2005
9	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 03/2007
7	Vomiting 01/2022 - 03/2007
7	Autism Spectrum Disorder 01/2021 - 03/2015
7	Autistic Disorder (Autism) 06/2017 - 01/2004
7	Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder) 02/2017 - 06/2011
7	Conduct Disorder (Conduct Disorders) 09/2014 - 01/2004
6	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 02/2003
6	Substance-Related Disorders (Drug Abuse) 02/2017 - 01/2009
5	Fatigue 01/2022 - 07/2006
5	Dizziness (Lightheadedness) 01/2022 - 07/2006
5	Anxiety Disorders (Anxiety Disorder) 01/2018 - 01/2005
4	Psychomotor Agitation (Akathisia) 08/2017 - 11/2008
4	Movement Disorders (Movement Disorder) 01/2014 - 01/2005
4	Abdominal Pain (Pain, Abdominal) 03/2013 - 03/2006
3	Mood Disorders (Mood Disorder) 06/2017 - 08/2006
3	Disorders of Excessive Somnolence (Hypersomnia) 10/2016 - 09/2010
3	Obesity 10/2013 - 03/2009
2	Paresthesia (Dysesthesia) 04/2018 - 06/2005
2	Pain (Aches) 04/2015 - 01/2012
2	Oppositional Defiant Disorder 09/2014 - 08/2006
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2014 - 07/2012
2	Diarrhea 09/2013 - 06/2005
2	Tremor (Tremors) 03/2013 - 11/2008
2	Cyclothymic Disorder 01/2012 - 05/2007
2	Depressive Disorder (Melancholia) 06/2011 - 03/2009
2	Lethargy 09/2010 - 08/2002
2	Basal Ganglia Diseases (Basal Ganglia Disease) 10/2009 - 11/2008
1	Cardiotoxicity 01/2021
1	Smith-Magenis Syndrome 08/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Hypesthesia (Numbness) 04/2018
1	Dysgeusia (Parageusia) 04/2018

Drug/Important Bio-Agent (IBA)

26	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 02/2003
20	Methylphenidate (Ritalin)FDA LinkGeneric 01/2018 - 03/2002
19	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2020 - 08/2002
19	LithiumIBA 09/2019 - 02/2004
15	Lisdexamfetamine Dimesylate FDA Link 12/2022 - 03/2007
13	Valproic Acid (Depakote)FDA LinkGeneric 09/2019 - 08/2003
13	Aripiprazole (Abilify)FDA Link 12/2017 - 08/2008
10	Olanzapine (Zyprexa)FDA Link 09/2019 - 02/2003
10	Quetiapine Fumarate (Seroquel)FDA Link 09/2019 - 01/2002
9	Pharmaceutical PreparationsIBA 02/2017 - 06/2002
8	ProlactinIBA 01/2022 - 08/2006
7	Molindone (Molindone Hydrochloride)FDA Link 01/2021 - 08/2007
7	Antidepressive Agents (Antidepressants)IBA 01/2021 - 11/2007
7	asenapine FDA Link 09/2019 - 06/2015
6	ViloxazineIBA 07/2021 - 01/2020
6	Guanfacine (Tenex)FDA LinkGeneric 01/2018 - 08/2007
6	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2018 - 02/2011
6	Amphetamine (Amfetamine)FDA LinkGeneric 01/2012 - 09/2005
5	Fluoxetine (Prozac)FDA LinkGeneric 01/2022 - 11/2004
5	Lurasidone Hydrochloride FDA Link 01/2022 - 12/2015
4	LipidsIBA 01/2022 - 09/2013
4	MelatoninIBA 01/2021 - 11/2017
3	ziprasidone (Geodon)FDA Link 01/2022 - 10/2013
3	VortioxetineIBA 01/2022 - 08/2017
3	Clonidine (ST 155)FDA LinkGeneric 01/2018 - 02/2011
3	Desvenlafaxine Succinate FDA Link 01/2018 - 05/2014
3	Biological ProductsIBA 08/2012 - 05/2007
2	Vilazodone HydrochlorideIBA 01/2020 - 08/2018
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2019 - 02/2004
2	TabletsIBA 08/2019 - 06/2011
2	Anticonvulsants (Antiepileptic Drugs)IBA 03/2018 - 01/2016
2	N-Methylaspartate (NMDA)IBA 06/2017 - 02/2007
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2017 - 02/2007
2	Memantine (Namenda)FDA Link 06/2017 - 02/2007
2	Lamotrigine (Lamictal)FDA LinkGeneric 12/2015 - 01/2010
2	Glucose (Dextrose)FDA LinkGeneric 06/2015 - 10/2013
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2015 - 01/2012
2	Escitalopram FDA Link 09/2013 - 03/2006
2	A 7 (A-7)IBA 08/2013 - 02/2013
2	Insulin (Novolin)FDA Link 02/2012 - 11/2008
2	Dopamine (Intropin)FDA LinkGeneric 01/2012 - 11/2008
2	ProdrugsIBA 07/2008 - 03/2007
2	Delayed-Action PreparationsIBA 05/2008 - 09/2005
2	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 08/2007 - 04/2007
2	4,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA 08/2006 - 01/2004
2	Lithium Carbonate (Eskalith)FDA LinkGeneric 05/2005 - 08/2003
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2021
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 06/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Protons (Proton)IBA 01/2019
1	4- (3,4- dichlorophenyl)- 1,2,3,4- tetrahydronaphthalen- 1- amineIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019

Therapy/Procedure

21	Therapeutics 09/2014 - 08/2003
20	Drug Therapy (Chemotherapy) 01/2021 - 01/2004
1	Tai Ji (Tai Chi Chuan) 06/2020
1	Sublingual Administration 04/2018